|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
D14.0 |
Benign neoplasm of middle ear, nasal cavity and accessory sinuses
|
D140 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 60.10%
|
19.97%
|
7.56%
|
4.55%
|
3.05%
|
1.54%
|
0.84%
|
0.62%
|
0.95%
|
0.26%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D14.0*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
639
|
1,119
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
523
|
21,402
|
|
J3010
|
FENTANYL CITRATE INJECTION |
500
|
1,543
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
468
|
468
|
|
J2405
|
ONDANSETRON HCL INJECTION |
458
|
1,886
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
425
|
3,478
|
|
31231
|
NASAL ENDOSCOPY DX |
333
|
333
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
316
|
2,699
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
233
|
1,136
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
229
|
908
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
222
|
650
|
|
31267
|
ENDOSCOPY MAXILLARY SINUS |
212
|
212
|
|
61782
|
SCAN PROC CRANIAL EXTRA |
190
|
190
|
|
31237
|
NSL/SINS NDSC SURG BX POLYPC |
189
|
189
|
|
J2370
|
PHENYLEPHRINE HCL INJECTION |
179
|
630
|
|
88331
|
PATH CONSLTJ SURG 1 BLK 1SPC |
175
|
315
|
|
88304
|
TISSUE EXAM BY PATHOLOGIST |
164
|
238
|
|
J7120
|
RINGERS LACTATE INFUSION |
164
|
210
|
|
J2001
|
LIDOCAINE INJECTION |
142
|
1,313
|
|
J0330
|
SUCCINYCHOLINE CHLORIDE INJ |
141
|
906
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D14.0 related to the following DRG Codes:
011-013
154-156
|
